Tarsus Pharma annual meeting elects two Class I directors, ratifies Ernst & Young auditor

Tarsus Pharmaceuticals, Inc.

Bhaskar Chaudhuri (21.8M for, 2.9M withheld) and William Link (20.8M for, 3.9M withheld) elected as Class I directors.
Ratification of Ernst & Young as auditor for FY2024: 31.9M for, 24.9K against, 57.3K abstain.
Total shares voted: 31,978,938 out of 37,776,665 outstanding, quorum achieved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.